Annual Total Long Term Liabilities
$346.62 M
-$76.12 M-18.01%
December 31, 2023
Summary
- As of February 7, 2025, APLS annual total long term liabilities is $346.62 million, with the most recent change of -$76.12 million (-18.01%) on December 31, 2023.
- During the last 3 years, APLS annual total long term liabilities has fallen by -$281.07 million (-44.78%).
- APLS annual total long term liabilities is now -44.78% below its all-time high of $627.68 million, reached on December 31, 2020.
Performance
APLS Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$473.49 M
+$2.50 M+0.53%
September 30, 2024
Summary
- As of February 7, 2025, APLS quarterly total long term liabilities is $473.49 million, with the most recent change of +$2.50 million (+0.53%) on September 30, 2024.
- Over the past year, APLS quarterly long term liabilities has increased by +$126.87 million (+36.60%).
- APLS quarterly long term liabilities is now -30.74% below its all-time high of $683.62 million, reached on June 30, 2021.
Performance
APLS Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
APLS Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.0% | +36.6% |
| 3 y3 years | -44.8% | -14.1% |
| 5 y5 years | +1257.3% | -14.1% |
APLS Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -37.1% | at low | -15.3% | +36.6% |
| 5 y | 5-year | -44.8% | +19.8% | -30.7% | +63.7% |
| alltime | all time | -44.8% | -100.0% | -30.7% | -100.0% |
Apellis Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $473.49 M(+0.5%) |
| Jun 2024 | - | $470.99 M(+34.6%) |
| Mar 2024 | - | $349.96 M(+1.0%) |
| Dec 2023 | $346.62 M(-18.0%) | $346.62 M(-13.4%) |
| Sep 2023 | - | $400.31 M(+1.3%) |
| Jun 2023 | - | $395.34 M(-7.7%) |
| Mar 2023 | - | $428.10 M(+1.3%) |
| Dec 2022 | $422.74 M(-23.3%) | $422.74 M(-6.1%) |
| Sep 2022 | - | $450.03 M(-16.9%) |
| Jun 2022 | - | $541.29 M(-3.1%) |
| Mar 2022 | - | $558.85 M(+1.4%) |
| Dec 2021 | $551.26 M(-12.2%) | $551.26 M(+12.8%) |
| Sep 2021 | - | $488.78 M(-28.5%) |
| Jun 2021 | - | $683.62 M(+1.3%) |
| Mar 2021 | - | $674.80 M(+7.5%) |
| Dec 2020 | $627.68 M | $627.68 M(+6.9%) |
| Sep 2020 | - | $587.22 M(+1.2%) |
| Jun 2020 | - | $580.05 M(+53.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $379.20 M(+31.1%) |
| Dec 2019 | $289.26 M(+1032.8%) | $289.26 M(+2.5%) |
| Sep 2019 | - | $282.22 M(+131.3%) |
| Jun 2019 | - | $122.03 M(+66.7%) |
| Mar 2019 | - | $73.21 M(+186.7%) |
| Dec 2018 | $25.54 M(-4.1%) | $25.54 M(-6.0%) |
| Sep 2018 | - | $27.16 M(+0.5%) |
| Jun 2018 | - | $27.01 M(+0.5%) |
| Mar 2018 | - | $26.87 M(+0.9%) |
| Dec 2017 | $26.63 M(>+9900.0%) | $26.63 M(>+9900.0%) |
| Sep 2017 | - | $0.00(-100.0%) |
| Jun 2017 | - | $26.57 M(>+9900.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00 |
| Dec 2013 | $0.00 | - |
FAQ
- What is Apellis Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Apellis Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Apellis Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of APLS is $346.62 M
What is the all time high annual total long term liabilities for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual total long term liabilities is $627.68 M
What is Apellis Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, APLS annual total long term liabilities has changed by -$76.12 M (-18.01%)
What is Apellis Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of APLS is $473.49 M
What is the all time high quarterly long term liabilities for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly total long term liabilities is $683.62 M
What is Apellis Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, APLS quarterly total long term liabilities has changed by +$126.87 M (+36.60%)